DamianPaulAlagiaIIIMDMS, MBA

Chief Clinical Officer Health Systems / Senior Medical Director for Women's and Advanced Diagnostics

Dr. Alagia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Alagia is the Chief Clinical Officer for Health Systems for Quest Diagnostics as well as the Senior Medical Director for Advanced Diagnostics and Women’s Health. Prior to coming to Quest Diagnostics, he served in senior level positions in large non- profit health systems, in venture capital backed portfolio companies, and in academic medical centers. He is an experienced innovative an entrepreneurial health care executive as well as an expert clinician, surgeon, and academician.

Dr. Alagia is a board certified obstetrician and gynecologist who is both a fellow of the American College of Surgeons and the American College of Obstetrics and Gynecology. He is a graduate of Georgetown University College and Medical School and holds Masters Degrees in Business and Finance from The Johns Hopkins University.

Top 100 CMOs in US Becker's Review, 2016
Top US Doctors US News and World Report, 2012
Hall of Honors Inductee Saint Xavier High School, 2008
America's Top Obstetricians & Gynecologists Consumers Research Council of America, 2004
Washington's Best Doctors Washingtonian Magazine, 1999, 2002, 2004, 2006, 2008
Hugh H. Hussey Medical Student Teaching Award Georgetown University, 1987-1988
Barrett Medal Recipient Georgetown University College of Arts and Sciences, 1978
Most Compassionate Doctor American Registry
Fellow (FACS) American College of Surgeons
Join now to see all

PubMed

4 citations
Maternal red blood cell alloimmunization prevalence in the United States.
Ronan P Sugrue, Kenneth J Moise, Jerome J Federspiel, Elizabeth Abels, Judy Z Louie
Blood Advances. 2024-08-27
Chlamydia and Gonorrhea Testing in Pregnancy: Time to Improve Adherence and Update Recommendations.
Harvey W Kaufman, Damian P Alagia, Ky Van, Barbara Van Der Pol
Journal of Lower Genital Tract Disease. 2024-07-26
5 citations
Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010 to 2018.
Justin K. Niles, Harvey W. Kaufman, Thomas A. Peterman, Guoyu Tao, Thomas L. Gift
Sexually Transmitted Diseases. 2021-06-23

Journal Articles

An Objective Structured Assessment of Technical Skills (OSATS) in Operative Hysteroscopy
E. Chahine, V. Janakiraman, J. Robinson, D. Alagia, C. Marfori, N. Gaba, J. Keller, Journal of Minimally Invasive Gynecology, 1/1/2008

Lectures

The Changing Role of the Chief Medical Officer; Bringing Value and Innovation to the Healthcare System
Alexandria, VA - 1/1/2015
The Safety, Efficacy, and Durability of Renessa in a Well Defined Patient Population
Pittsburg, PA - 1/1/2012
Nonsurgical Transurethral Radiofrequency Collagen Denaturation: Results at Three Years after Treatment
Atlanta, GA - 1/1/2012
New Data Supporting the Office Based Use of Renessa
Chicago, IL - 1/1/2011
The Safety and Efficacy of Renessa: A Review of Current Literature and Supporting Materials
Harrisburg, PA - 1/1/2011
The Safety of Transurethral Radio Frequency Remodeling of the Proximal Urethra
Newark, CA - 1/1/2010
The Safety and Efficacy of Renessa: A Review of Current Literature with Subject Matter Expert Comments
Baltimore, MD - 1/1/2010
Acquisition Opportunities in the Physician Owned Specialty Hospital Market
Hamilton, Bermuda - 1/1/2009
Changing and Improving the Models of Patient Care
Chicago, IL - 1/1/2009
Join now to see all

Other

Renessa Objective and Subjective Efficacy Study. Medical device clinical trial protocol creation, development, and implementation. Single arm, open label, post market ...
Alagia D
1/1/2011

Quest Introduces Specimen Self-Collection for Genital Tract Infection TestingOctober 15th, 2024
Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of over 4 Million PregnanciesAugust 12th, 2024
Decreased Testing Could Lead to Surge in Sexually Transmitted InfectionsMay 25th, 2021